Shares of Inovio Pharmaceuticals Inc. INO slipped 2.91% to $4.01 Tuesday, on what proved to be an all-around favorable ...

In the past month, shares of INO have skyrocketed 134.2% compared with the industry’s 6.5% rise. The significant uptick in the stock price was observed after the company announced plans to ...

Shares of Inovio Pharmaceuticals ($INO) slipped nearly 2% on Thursday afternoon ahead of the company’s third-quarter results, ...

Inovio Pharmaceuticals (NASDAQ:INO – Free Report) had its price objective cut by Royal Bank of Canada from $7.00 to $6.00 in ...

Inovio Pharmaceuticals (NASDAQ: INO) Q3 2024 Earnings Call Nov 14, 2024, 4:30 p.m. ET ...

Analyst Stephens covers INOVIO Pharmaceuticals highlighting its diverse clinical pipeline and FDA's consideration of INO-3107 Phase 1/2 trials for Accelerated Approval. Potential as the first non ...

The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Inovio Pharmaceuticals wasn’t one of them. The 10 stocks that ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

INO) has entered into a sales agreement with Oppenheimer & Co. Inc. The agreement, which allows for the potential sale of common stock at the company's discretion, could total up to $60 million.